Energy Transfer LP (ET) closed the last trading session at $17.90, gaining 13.2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $22.93 indicates a 28.1% upside potential.The average comprises 14 short-term price targets ranging from a low of $19 to a high of $26, with a standard deviation of $1.94. While the lowest estimate indicates an increase of 6.2% from the current price leve ...

Shares of Knot Offshore (KNOP) have gained 0.3% over the past four weeks to close the last trading session at $6.39, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $13.17 indicates a potential upside of 106.1%.The average comprises three short-term price targets ranging from a low of $12 to a high of $15, with a standard deviation of $1.61. While the lowest estimate indicates a ...

Shares of Intellia Therapeutics, Inc. (NTLA) have gained 6.1% over the past four weeks to close the last trading session at $7.69, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $38.32 indicates a potential upside of 398.3%.The average comprises 25 short-term price targets ranging from a low of $7 to a high of $106, with a standard deviation of $24.94. While the lowest estimate ...

Shares of HNI (HNI) have gained 8.8% over the past four weeks to close the last trading session at $47.26, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $69.50 indicates a potential upside of 47.1%.The average comprises four short-term price targets ranging from a low of $63 to a high of $80, with a standard deviation of $7.59. While the lowest estimate indicates an increase o ...

Key Takeaways SLF aims to become one of the top five players in its voluntary benefits business. SLF maintains a sturdy capital position, enabling consistent wealth distribution. Sun Life Financial's shares have gained 9.4% year to date compared with the industry's growth of 2%.Sun Life Financial Inc.  (SLF) hit a 52-week high of $65.28 on June 3. Shares closed at $64.91 after gaining 9.4% year to date, outperforming the industry, the sector and the Zacks S&P 500 composite.Sun Life Financial has outperfor ...

Key Takeaways NUE, STLD and CLF stand to benefit from new 50% tariffs that favor domestic steel producers. NUE and STLD will benefit from smart investments and investor-friendly moves. CLF expects $50/ton in cost savings for 2025 and a strong earnings rebound by 2026.U.S. President Donald Trump does it again. In a bid to protect American industry, he has doubled down, literally, on his favorite economic weapon — tariffs. Effective today, the United States has raised import duties on steel and aluminum fro ...

Key Takeaways DAVE, NOMD, GLDD and NGS all show rising cash flows, signaling improved operational efficiency Each stock meets key criteria, including strong VGM Scores, robust broker ratings and a price of more than $5 Earnings estimates for all four stocks have been revised upward, reflecting increased investor confidenceIf achieving profit is a company’s goal, then having a healthy cash flow is highly essential for its existence, development and success. This is because cash offers the flexibility to ma ...

Here is the stock with buy rank and strong momentum characteristics for investors to consider today, June 4th:BioCryst Pharmaceuticals (BCRX) : This company which is a leader in the use of crystallography and structure-based drug design for the development of novel therapeutics to treat cancer, cardiovascular diseases, autoimmune diseases, and viral infections, has a Zacks Rank #1(Strong Buy), and witnessed the Zacks Consensus Estimate for its next year earnings increasing 83.3% over the last 60 days.BioCry ...

Core Insights - NVIDIA has reclaimed its position as the world's most valuable company with a market capitalization of $3.45 trillion, surpassing Microsoft due to high demand for its AI hardware [1] - The company's stock has surged nearly 50% since early April, adding over $1 trillion in market cap, driven by strong earnings and AI chip demand [2] - Despite U.S. export restrictions to China, NVIDIA has strategically accelerated the delivery of its AI servers to key customers like Microsoft [3] Financial Performance - NVIDIA reported record-breaking revenues, primarily from its data center business, which saw a 73% year-over-year increase to $39.1 billion [4] - The stock is currently trading at a P/E ratio of 32.40, slightly below the industry average of 32.80, indicating a favorable valuation [8] - The PEG ratio stands at 1.15, significantly lower than the industry average of 2.18, suggesting better value for investors [9] Growth Drivers - The demand for NVIDIA's AI chips is surging, particularly among large cloud providers and for AI supercomputing [5] - NVIDIA is expanding its manufacturing capabilities in the U.S. and collaborating with partners to produce AI supercomputers [5] - The company is also accelerating global expansion with new AI factories planned in the U.S. and Saudi Arabia, and launching AI infrastructure in Abu Dhabi [6] Strategic Initiatives - CEO Jensen Huang announced plans for a new AI chip tailored for the Chinese market in response to U.S. export controls [7] - NVIDIA has expanded partnerships with major cloud providers, making its Blackwell-based cloud instances available on multiple platforms [6] Investment Opportunities - Several ETFs have significant exposure to NVIDIA, including Strive U.S. Semiconductor ETF (23.3% exposure) and VanEck Vectors Semiconductor ETF (21.5% exposure) [10] - For risk-tolerant investors, single-stock ETFs with 200% exposure to NVIDIA are available, such as T-REX 2X Long NVIDIA Daily Target ETF [11]

The market expects J.Jill (JILL) to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended April 2025. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates.The earnings report, which is expected to be released on June 11, 2025, might help the stock move higher if these key numbers are better th ...